SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-10-017594
Filing Date
2010-03-31
Accepted
2010-03-31 17:09:05
Documents
7
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 v179506_10k.htm 10-K 552735
2 v179506_ex4-1.htm EX-4.1 93884
3 v179506_ex10-5.htm EX-10.5 72594
4 v179506_ex31-1.htm EX-31.1 13484
5 v179506_ex31-2.htm EX-31.2 13559
6 v179506_ex32-1.htm EX-32.1 5842
7 v179506_ex32-2.htm EX-32.2 5845
  Complete submission text file 0001144204-10-017594.txt   759481
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-53127 | Film No.: 10720258
SIC: 4731 Arrangement of Transportation of Freight & Cargo